Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update

Non-alcoholic fatty liver disease (NAFLD) is the predominant cause of chronic liver disease worldwide. NAFLD progresses in some cases to non-alcoholic steatohepatitis (NASH), which is characterized, in addition to liver fat deposition, by hepatocyte ballooning, inflammation and liver fibrosis, and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sofogianni, Areti, Filippidis, Athanasios, Chrysavgis, Lampros, Tziomalos, Konstantinos, Cholongitas, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475780/
https://www.ncbi.nlm.nih.gov/pubmed/32952876
http://dx.doi.org/10.4254/wjh.v12.i8.493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475780/
https://www.ncbi.nlm.nih.gov/pubmed/32952876
http://dx.doi.org/10.4254/wjh.v12.i8.493

Ejemplares similares